RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This trial compares two treatment methods:
1. Orlistat 60 mg to be taken three times daily one capsule; indicated for weight loss in
overweight adults. Important is also that it is taken along with a reduced-calorie and
low-fat diet.
2. Polyglucosamine tablets to be taken two times daily two tablets, taken with the two main
meals with the highest fat content, indicated for weight maintenance and weight loss.